Suppr超能文献

更大口径的 ACE 68 抽吸导管可提高 ADAPT 技术的首次通过效果。

Larger ACE 68 aspiration catheter increases first-pass efficacy of ADAPT technique.

机构信息

Division of Neurointerventional Radiology, Neuroscience Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

Division of Vascular Neurology, Neuroscience Institute, Abbott Northwestern Hospital, Minneapolis, Minnesota, USA.

出版信息

J Neurointerv Surg. 2019 Feb;11(2):141-146. doi: 10.1136/neurintsurg-2018-013957. Epub 2018 Jul 3.

Abstract

PURPOSE

To report the efficacy of A Direct Aspiration first-Pass Thrombectomy (ADAPT) technique with larger-bore ACE aspiration catheters as first-line treatment for anterior circulation emergent large vessel occlusions (ELVOs), and assess for the presence of a first-pass effect with ADAPT.

METHODS

We retrospectively reviewed 152 consecutive patients with anterior circulation ELVOs treated with the ADAPT technique as first-line treatment using ACE60, 64, or 68 at our institution. Baseline characteristics, procedural variables, and modified Rankin Scale (mRS) at 90 days were recorded.

RESULTS

Fifty-seven patients were treated with ACE60 (37.5%), 35 with ACE64 (23%), and 60 with ACE68 (39.5%). Median groin puncture to reperfusion time was 30 min with ACE60, 26 min with ACE64, and 19.5 min with ACE68. Successful reperfusion after the first ADAPT pass was 33% with ACE60 and 53% with ACE68 (P=0.04). The stent-retriever rescue rate was 26% with ACE60, 3% with ACE64, and 10% with ACE68 (P=0.004). In multivariate logistic regression analysis, use of the ACE68 aspiration catheter was an independent predictor of successful reperfusion after the first ADAPT pass (P=0.016, OR1.67, 95% CI 1.1 to 2.54), and successful reperfusion after the first ADAPT pass was an independent predictor of good clinical outcome at 90 days (P=0.0004, OR6.2, 95% CI 2.27 to 16.8).

CONCLUSION

Use of the larger-bore ACE 68 aspiration catheter was associated with shorter groin puncture to reperfusion time, higher rate of successful reperfusion after the first ADAPT pass, and lower rate of stent-retriever rescue. Further, a first-pass effect was demonstrated in our ADAPT patient cohort.

摘要

目的

报告使用较大口径 ACE 抽吸导管的直接抽吸首次通过血栓切除术(ADAPT)技术作为治疗前循环紧急大血管闭塞(ELVO)的一线治疗方法的疗效,并评估 ADAPT 中的首次通过效应。

方法

我们回顾性分析了在我院接受 ADAPT 技术治疗的 152 例前循环 ELVO 患者,使用 ACE60、64 或 68 抽吸导管作为一线治疗。记录基线特征、操作变量和 90 天改良 Rankin 量表(mRS)。

结果

57 例患者接受 ACE60(37.5%)治疗,35 例患者接受 ACE64(23%)治疗,60 例患者接受 ACE68(39.5%)治疗。ACE60 的股动脉穿刺至再通时间中位数为 30 分钟,ACE64 为 26 分钟,ACE68 为 19.5 分钟。首次 ADAPT 通过后成功再通率 ACE60 为 33%,ACE68 为 53%(P=0.04)。支架取栓挽救率 ACE60 为 26%,ACE64 为 3%,ACE68 为 10%(P=0.004)。多变量逻辑回归分析显示,使用 ACE68 抽吸导管是首次 ADAPT 通过后成功再通的独立预测因素(P=0.016,OR1.67,95%CI 1.1 至 2.54),首次 ADAPT 通过后成功再通是 90 天良好临床结果的独立预测因素(P=0.0004,OR6.2,95%CI 2.27 至 16.8)。

结论

使用较大口径 ACE 68 抽吸导管与股动脉穿刺至再通时间更短、首次 ADAPT 通过后再通率更高、支架取栓挽救率更低相关。此外,我们的 ADAPT 患者队列中存在首次通过效应。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验